Literature DB >> 4413111

Effects of a long-acting antiarrhythmic agent--QX-572--on therapy resistant ventricular tachyarrhythmias.

L Rydén, A Hjalmarson, H Wasir, L Werkö.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4413111      PMCID: PMC458899          DOI: 10.1136/hrt.36.8.811

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  8 in total

1.  ANTIARRHYTHMIC AND NEUROMUSCULAR EFFECTS OF QX-572 IN MAN.

Authors:  R L KATZ
Journal:  Acta Anaesthesiol Scand       Date:  1965       Impact factor: 2.105

2.  Protein synthesis from aminoacyl-soluble ribonucleic acid.

Authors:  D NATHANS; R MONRO; F LIPMANN
Journal:  Fed Proc       Date:  1962 Jan-Feb

Review 3.  The pharmacology and clinical use of lidocaine as an antiarrhythmic drug--1972.

Authors:  D C Harrison; E L Alderman
Journal:  Mod Treat       Date:  1972-02

4.  [Experiences of the coronary-care unit at Sahlgrenska hospital].

Authors:  R Henning; S Holmberg
Journal:  Lakartidningen       Date:  1971-08-04

Review 5.  The use of procaine amide and lidocaine in the treatment of cardiac arrhythmias.

Authors:  J T Bigger; R H Heissenbuttel
Journal:  Prog Cardiovasc Dis       Date:  1969-05       Impact factor: 8.194

6.  Clinical pharmacology of N,N-bis(phenylcarbamolymethyl)dimethylammonium chloride (QX-572), a new antiarrhythmic agent.

Authors:  M L Schwartz; J Stapleton; B G Covino
Journal:  J Clin Pharmacol J New Drugs       Date:  1967 Sep-Oct

Review 7.  Antiarrhythmic agents. I. Mechanisms of action and clinical pharmacology.

Authors:  D T Mason; A N DeMaria; E A Amsterdam; R Zelis; R A Massumi
Journal:  Drugs       Date:  1973       Impact factor: 9.546

8.  ANTIARRHYTHMIC ACTION OF N, N-BIS (PHENYLCARBAMOYLMETHYL) DIMETHYL AMMONIUM CHLORIDE (QX-572) IN CAT AND DOG.

Authors:  R L KATZ
Journal:  Anesthesiology       Date:  1964 May-Jun       Impact factor: 7.892

  8 in total
  1 in total

1.  Plasma concentrations and urinary excretion of the antiarrhythmic quaternary ammonium compound QX-572 in man.

Authors:  L Rydén; A Berlin; L R Treiber
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.